Area of research
Infectious Diseases · Immunology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Immune Cell Function and Interaction, Chronic Myeloid Leukemia Treatments, and Chronic Lymphocytic Leukemia Research.
Novel African Rhinolophus bat ACE2 sequences reveal the determinants of Afro-Eurasian sarbecovirus entry
Molecular basis of sarbecovirus evolution and receptor tropism in natural hosts, potential intermediate hosts, and humans.
Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236.
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant.
Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant.
ORF3c is expressed in SARS‐CoV‐2‐infected cells and inhibits innate sensing by targeting MAVS
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
ORF3c is expressed in SARS-CoV-2-infected cells and inhibits innate sensing by targeting MAVS.
Impact of Imprinted Immunity Induced by mRNA Vaccination in an Experimental Animal Model.
Determination of the factors responsible for the tropism of SARS-CoV-2-related bat coronaviruses to <i>Rhinolophus</i> bat ACE2.
Identification and characterization of the genome of a papillomavirus from skin lesions of four-toed hedgehogs (Atelerix albiventris).
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.
Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies.
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant.
Structural Insight into the Resistance of the SARS-CoV-2 Omicron BA.4 and BA.5 Variants to Cilgavimab.
Identification of amino acid substitutions escaping from a broadly neutralizing monoclonal antibody of feline calicivirus.